ANAntónio Nunes

António Nunes

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


António Nunes has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Characterization of Liquid Formulations for Enhanced Buccal Permeation: Exploring Key Attributes

    by Ariana Sena, Andreia Tabanez, Francisca Bastos, Alain Costa, António Nunes, Sérgio Simões

    Background: Buccal administration offers direct access to systemic circulation, improving drug bioavailability when compared with the conventional oral route. This advantage depends on the formulation’s ability to remain in contact with the buccal mucosa. Attributes such as adhesion and viscosity are suggested to be correlated and contribute to enhanced residence time at the administration site. Methods: Buccal formulations with varying hydroxypropyl cellulose concentrations were prepared. Adhesion, viscosity, and residence time were assessed using a novel combined qualitative and quantitative approach. Drug permeation was evaluated in vitro using a biomimetic membrane and ex vivo using porcine buccal tissue, and it was further enhanced by adding the permeation enhancer benzalkonium chloride. Permeability measurements were integrated with residence time to estimate effective drug delivery. Results: Increasing HPC concentration improved both adhesion and viscosity, with 2% HPCs (F2) showing the strongest effect (45.5 ± 13.7 g), correlating with longer residence time (43.4% drug retained at 2 min vs. ~20% for 0–1% HPC). Although the polymer slightly reduced apparent permeability, when residence time was considered, drug flux increased 1.6-fold compared to the polymer-free formulation (F0), rising from 12.9 × 10−5 cm/min (F0) to 19.4 × 10−5 cm/min (F2) after 2 min. The addition of BKC further enhanced permeation, with apparent permeability increasing 1.5-fold vs. F2 and 2.5-fold vs. F0. Conclusions: Buccal liquid preparations’ efficacy is influenced by residence time and subsequent drug permeation. Residence time benefits from the synergistic effects of adhesion and viscosity, highlighting the importance of experimentally assessing these parameters during the development of oromucosal products.


  • Integrating microfluidics and streamlined remote drug loading: one step closer to continuous manufacturing of liposomal injectables containing small drugs

    by Mariana Biscaia-Caleiras, Diana Lopes, Carolina Henriques, Ana Sofia Lourenço, António Nunes, Manuel Bañobre, João Nuno Moreira, Sérgio Simões


  • Bridging membrane fluidity studies with a predictive model of drug encapsulation to address industrial challenges of liposomal injectables manufacturing

    by Mariana Biscaia-Caleiras, Nuno Fonseca, Ana Sofia Lourenço, António Nunes, Abel Ferreira, João Nuno Moreira, Sérgio Simões

    Industrial manufacturing of liposomal drugs, often involves high-temperature processes, resulting in increased energy consumption, prolonged process times, and elevated costs, while posing risks of phospholipid and drug degradation. The current study addresses these challenges by exploring remote loading of doxorubicin into liposomes, at temperatures below the phase transition temperature (PTT) of the primary phospholipid (DSPC, 55 °C). Drug loading efficiencies exceeding 90% at 45 °C were achieved, while efficiencies dropped significantly (6-fold and 23-fold) at 37 °C and 25 °C, respectively. This prompted the hypothesis that efficient drug loading might be attained below the PTT, when a minimal threshold for liposomal membrane fluidity is overcome. Using design of experiments (DoE), key factors influencing fluidity were identified: temperature, cholesterol content and surface tension (dependent on the isotonic agent). A full factorial DoE confirmed that membrane fluidity increased with lower surface tension, and high cholesterol content. A predictive model was also generated establishing a correlation between drug loading efficiency, membrane fluidity, and drug partitioning coefficient (logP). This model revealed that doxorubicin (logP = 1.5) requires a fluidity threshold of 4.41 for efficient loading (≥ 90%), whereas daunorubicin (logP = 2.32) needs a lower threshold of 3.85, suggesting that drugs with higher logP values demand lower fluidity thresholds for effective loading. The model’s applicability was validated across various lipid formulations, enabling effective drug loading at temperatures as low as 25 °C, potentially reducing degradation risks and energy costs. Overall, these findings highlight the relevance of liposomal membrane fluidity studies as a potential tool for enabling more effective industrial processes. Graphical Abstract


  • Development of a buccal in vitro permeation method – exploring aQbD implementation

    by Ariana Sena, Alain Costa, Francisca Bastos, Ana Catarina Pinto, Carla Vitorino, António Nunes, Sérgio Simões


  • Oromucosal products – Market landscape and innovative technologies: A review

    by Francisca Bastos, Ana Catarina Pinto, António Nunes, Sérgio Simões


  • Open Access

    Multi-Aspect Optoacoustic Imaging of Breast Tumors under Chemotherapy with Exogenous and Endogenous Contrasts: Focus on Apoptosis and Hypoxia

    by Angelos Karlas, Antonio Nunes, Wouter Driessen, Evangelos Liapis, Josefine Reber

    Breast cancer is a complex tumor type involving many biological processes. Most chemotherapeutic agents exert their antitumoral effects by rapid induction of apoptosis. Another main feature of breast cancer is hypoxia, which may drive malignant progression and confer resistance to various forms of therapy. Thus, multi-aspect imaging of both tumor apoptosis and oxygenation in vivo would be of enormous value for the effective evaluation of therapy response. Herein, we demonstrate the capability of a hybrid imaging modality known as multispectral optoacoustic tomography (MSOT) to provide high-resolution, simultaneous imaging of tumor apoptosis and oxygenation, based on both the exogenous contrast of an apoptosis-targeting dye and the endogenous contrast of hemoglobin. MSOT imaging was applied on mice bearing orthotopic 4T1 breast tumors before and following treatment with doxorubicin. Apoptosis was monitored over time by imaging the distribution of xPLORE-APOFL750©, a highly sensitive poly-caspase binding apoptotic probe, within the tumors. Oxygenation was monitored by tracking the distribution of oxy- and deoxygenated hemoglobin within the same tumor areas. Doxorubicin treatment induced an increase in apoptosis-depending optoacoustic signal of xPLORE-APOFL750© at 24 h after treatment. Furthermore, our results showed spatial correspondence between xPLORE-APO750© and deoxygenated hemoglobin. In vivo apoptotic status of the tumor tissue was independently verified by ex vivo fluorescence analysis. Overall, our results provide a rationale for the use of MSOT as an effective tool for simultaneously investigating various aspects of tumor pathophysiology and potential effects of therapeutic regimes based on both endogenous and exogenous molecular contrasts.